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Proton conductanceMitochondrial uncoupling in skeletal muscle has raised a major interest as a therapeutic target for treatment
of obesity, insulin sensitivity, and age-related disease. These physiological effects could be demonstrated in
several mouse models ectopically expressing uncoupling protein 1 (UCP1). Here, we investigated whether
UCP1 expressed under the control of the human skeletal actin (HSA) promoter in mouse skeletal muscle can
be regulated, and whether it affects mitochondrial superoxide production. We show that the skeletal muscle
UCP1 can be fully inhibited by a purine nucleotide (GDP) and reactivated by fatty acids (palmitate). During
mitochondrial resting state (State 4), mitochondrial superoxide production is about 76% lower in transgenic
mice. We suggest that this reduction is due to uncoupling activity as the administration of GDP restores
superoxide production to wildtype levels. Our study conﬁrms native behaviour of UCP1 in skeletal muscle
and demonstrates beneﬁcial effects on prevention of mitochondrial reactive oxygen species production
which may reduce age-related deleterious processes.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Uncoupling protein 1 is usually located in the mitochondrial inner
membrane of brown adipose tissue where it uncouples substrate
oxidation by the respiratory chain from ATP synthesis [1]. Substrate
oxidation by the respiratory chain builds up a proton motive force by
proton pumping of the respiratory complexes. UCP1 allows the return
of protons into the matrix without ATP synthesis and thereby
dissipates proton motive force as heat. UCP1-mediated heat produc-
tion plays an important role in non-shivering thermogenesis in small
rodents, hibernators and human infants [2].
Random energy dissipation may cause severe problems for the
energy budget of an animal and therefore, UCP1 activity is tightly
regulated. UCP1 can be activated by free fatty acids, superoxide and
reactive alkenals, and potently inhibited by purine nucleoside di- and
triphosphates [3–5].
The uncoupling activity by UCP1 may also have a physiological role
in the regulation of energy metabolism and has attracted studies as a
potential therapeutic target for obesity treatment. Recently, it has been
demonstrated that UCP1 ablation itself induced obesity [6]. In this
study, UCP1-ablated compared to wildtype mice gained more weight
even when kept at thermoneutrality, fed on either control or high fat
diet. In other studies, an increase of uncoupling activity by pharmaco-n Nutrition Arthur Scheunert
088322; fax: +493320088500.
.
ll rights reserved.logical manipulation such as administration of 2,4-Dinitrophenol
reduced obesity and improved insulin sensitivity in mice [7]. Dinitro-
phenol treatment, however, has a narrow dose range, and overdosing
led to illness or death [8]. Considering these observations, major
interest arises as to whether ectopic UCP1 expression in tissues other
than BAT may serve as a potential therapeutic target for anti-obesity
treatment. The detrimental attempt to use DNP in humans in the past
emphasizes the importance to understand the effect of uncoupling on
cellular mechanisms and physiological effects in animal models.
In order to control UCP1 function in tissues other than BAT, its
native behaviour towards activators (e.g. fatty acids) and inhibitors
(e.g. purine nucleotides) is mandatory. Functional studies on mouse
UCP1, overexpressed in yeast-mutants, displayed artifactual effects on
mitochondrial uncoupling at high protein levels, seen as GDP
insensitive uncoupling activity [9]. UCP1-containing cells showed a
growth defect suggesting that a proportion of UCP1-mediated
uncoupling is uncontrolled and ATP-synthesis capacity is compro-
mised. In accordance with this, in another study investigating yeast
expressing the UCP1-paralogue UCP3, UCP3 could neither be
stimulated by the known UCP3 activators palmitate and superoxide
nor inhibited by the purine nucleotide GDP [9]. These studies show
the lack of evidence for native uncoupling behaviour of mammalian
UCPs expressed in the yeast system. Although such studies should be
interpreted with caution due to signiﬁcant differences in species and
mitochondrial membrane composition, UCP3 also failed to be
activated by superoxide or inhibited by GDP in skeletal muscle of
transgenic mice overexpressing UCP3 [10].
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shows the importance to demonstrate native function of any
uncoupling protein that is introduced in different cell-types.
Skeletal muscle may represent a primary tissue for displaying
native protein function as a recent study shows that brown fat and
skeletal muscle cells, but not white adipose tissue (WAT) cells,
differentiate from a common precursor [11,12] suggesting that brown
fat cells are more similar to skeletal muscle cells than to WAT. So far,
several different transgenic mouse models with ectopic expression of
UCP1 in skeletal muscle have been generated independently andwere
shown to display reduced adiposity and increased energy expenditure
[13,14]. In a mouse line expressing rat UCP1 in heart and skeletal
muscle under the control of the mouse muscle creatine kinase (MCK),
regulated control of UCP1 activity was shown in isolated mitochon-
dria [15]. In this mouse line, there was a focus on obesity research,
while a recent study addressed beneﬁcial effects of UCP1 in skeletal
muscle on age-related diseases [16]. Aging is strongly related to
oxidative damage which accumulates with time, caused by reactive
oxygen species (ROS). Mitochondria are the main source of cellular
superoxide production leading to the generation of ROS. It has been
suggested that respiratory rates play an important role in the amount
of ROS production [17,18]. Superoxide production is very sensitive
towards a decrease in protonmotive force suggesting that uncoupling
activity and UCPs may play a role in decreasing ROS concentration in
the cell. Treatment with low doses of the uncoupler 2,4-dinitrophenol
promoted a decrease of ROS levels and subsequently, a decrease of
tissue DNA and protein oxidation [7]. Pertaining to UCPs, superoxide
and products of lipid peroxidation activate UCPs promoting a feedback
down-regulation of mitochondrial ROS production, although the
concentration of activators used in these studies were beyond
physiological levels [19]. This model is disputed as other studies
reported no involvement of UCP1 in 4-hydroxynonenal activation and
observed no altered UCP1 activation with manipulated matrix
superoxide levels [20,21]. The observation of decreased superoxide
induced DNA double strand break in UCP1 overexpressing endothelial
cells, however, indirectly indicates that UCP1may alter mitochondrial
superoxide levels [22].
Therefore, UCP1 may have a beneﬁcial impact on oxidative stress
in skeletal muscle.
In the present study, we investigated a HSA (human skeletal
muscle actin promoter)-transgenic mouse model expressing murine
UCP1 in skeletal but not heart muscle. Previously we have shown that
the HSA-mUCP1 mice had improved glucose tolerance and altered
substrate oxidation inmuscle and adipose tissue [13,23]. UCP1 protein
levels in skeletal muscle of these mice were approximately 14-fold
lower compared to levels normally found in BAT [23].
Functionality of UCP1 was judged by inhibition with purine
nucleotides and by re-activation with free fatty acids. To test whether
uncoupling affects mitochondrial superoxide production in skeletal
muscle, we measured mitochondrial hydrogen peroxide release by
ﬂuorescent detection.2. Methods
2.1. Animal experiments
Experiments were performed in adult (male, female) heterozy-
gous HSA-UCP1 transgenic mice and their wildtype littermates
established as described previously [24] . Mice were maintained at
22 °C a 12 h:12 h dark–light cycle with food and water ad libitum.
Mean body weights of wildtype and transgenic mice were 29.1
±3.2 g, and 21.3±1.8 g respectively. Prior to experiments, mice were
killed by cervical dislocation. The animal experiments were approved
by the animal welfare committee of the Ministry of Agriculture and
Environment (State of Brandenburg, Germany).2.2. Isolation of mitochondria
Mitochondrial preparations of the two genotypes were done in
parallel to correct for day-by-day variations in mitochondrial quality.
Skeletal muscle was obtained, minced and placed in ice-cold CP1
medium (0.1 M KCl, 0.05 M Tris–HCL, 2 mM EGTA, pH 7.4). The tissue
homogenate was then transferred to CP2 medium [CP1 to which was
added, 0.5% BSA, 5 mM MGCl2, 1 mM ATP, Protease Type VIII (Sigma
P5380)], digested for 3 min and homogenized using a Polytron
(Kinematica) followed by another 3 min digestion step. The
homogenate was centrifuged for 10 min at 490 g. The resulting
supernatant was ﬁltered through layers of muslime and centrifuged
for 10 min at 10,400 g. The resulting pellet was resuspended in CP1.
The high speed spin cycle was repeated twice and the ﬁnal pellet
resuspended in a minimum volume of CP1 medium.
The protein concentration of mitochondrial suspensions was
determined by the Biuret method using fatty acid free bovine serum
albumin (BSA; Sigma 3803) as standard.
2.3. Mitochondrial respiration
Oxygen consumption was measured using a Clarke-type electrode
(Rank Brothers Ltd, Cambridge, UK) maintained at 37 °C and
calibrated with air-saturated medium [120 mM KCl, 5 mM KH2PO4,
3 mM EGTA, 0.3% BSA, 5 μM rotenone (to inhibit complex I of the
respiratory chain) pH 7.2] which was assumed to contain
406 nmol O ml−1 [25]. Mitochondria were resuspended to a
concentration of 0.3 mg protein ml−1 in the assay medium.
Mitochondrial respiration was started by adding 4 mM succinate.
The hydrophobic fatty acid was equilibrated in BSA-containing
buffer for the proton leak assays, and dissolved in ethanol for
injections seen in Fig. 3. The ﬁnal concentration of the FFA was
calculated according to Richieri et al. 1993 [26].
2.4. Proton leak kinetics
The mitochondrial membrane potential was measured simulta-
neously with mitochondrial respiration by using an electrode
sensitive to the potential-sensitive probe, TPMP+ (triphenylmethyl-
phosphonium) in the presence of 100 nM nigericin to dissipate the pH
gradient, as described previously [27]. The TPMP+ sensitive electrode
was calibrated with sequential addition of TPMP+ up to 2.5 μM, and
succinate was added to initiate mitochondrial respiration. Membrane
potential and respiration were progressively inhibited by successive
steady states imposed by the competitive inhibitor, malonate, up to
2 mM.
Finally 0.3 μM FCCP was added to dissipate the membrane
potential and release all the TPMP+ from the mitochondria, allowing
correction for small baseline drifts. Leak respiration at each steady
state was plotted against the corresponding membrane potential to
illustrate the dependence of proton leak rate on membrane potential.
2.5. Measurement of mitochondrial superoxide production
The assay is based on the detection of H2O2 using Amplex red
ﬂuorogenic substrate (10-acetyl-3.7-dihydroxyphenoxazine; Invitro-
gen). The amplex red molecule reacts with H2O2 by a 1:1
stoichiometry to resoruﬁn, a ﬂuorescent molecule. In the presence
of superoxide dismutase, superoxide is converted to hydrogen
peroxide by a 1:2 stoichiometry. Measurements were performed
similar to Lambert et al. [31,40]. 10–20 μg skeletal muscle mitochon-
dria were incubated in assay buffer (50 mM KCl, 5 mM TES, 2 mM
MgCl2×6H2O, 4 mM KH2PO4, 1 mM EGTA, BSA 0.4% (w/v), pH 7.2
at RT) containing a cocktail of 50 μM Amplex Red, 30 U ml−1
superoxide dismutase (to convert extra-mitochondrial superoxide to
hydrogen peroxide), 6 Uml−1 horseradish peroxidase (catalyzing the
Fig. 2. Effect of GDP and palmitate on proton conductance of skeletal muscle
mitochondria in wt (A black symbols) and HSA-mUCP1 transgenic mice (B open
symbols) after GDP inhibition (squares) and after re-activation with 100 μM palmitate
(triangle) at 37 °C in the presence of 0.3% palmitate. While GDP and palmitate had no
effect on wildtype skeletal muscle mitochondria (A), in transgenics, GDP-inhibited
proton leak resulted in a downshift of the curve that could be partially restored by the
addition of palmitate.
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ﬂuorescent resoruﬁn) and 2 μg ml−1 oligomycin (to inhibit ATP
synthesis).
H2O2 formation was initiated by addition of succinate (4 mM) and
ﬂuorescence was detected at 37 °C in a microplate reader (BMG
Labtech, FLUOstar OPTIMA) in 96-well microplates (GREINER 96-Well
μClear, F-Bottom, black). The excitation wavelength was set to
550 nm, and the ﬂuorescence emission was detected at 585 nm.
Fluorescence was calibrated using known amounts of H2O2 at each
experimental day. Superoxide production was measured in the
presence of rotenone (2 μM, inhibiting complex I-derived ROS
production) and GDP (1 mM, to inhibit UCP1).
2.6. Statistical analysis
Data are given with means±SEM. Statistical signiﬁcance was
assessed by two-tailed Students t-test, and differences of Pb0.05
were considered signiﬁcant.
3. Results
3.1. Mitochondrial proton conductance of skeletal muscle from
transgenic vs wildtype mice
To address the question whether ectopically expressed UCP1
changes mitochondrial proton conductance in skeletal muscle, and
whether UCP1 displays native behavior, we determined proton
conductance in isolated skeletal muscle mitochondria. We measured
the full kinetic response of proton leak at 37 °C, measured as oxygen
consumption rate in the presence of oligomycin, to stepwise changes
in its driving force, membrane potential (Fig. 1). In contrast to
wildtype mice, the proton leak titration of transgenic mice was
shifted upwards demonstrating higher proton conductance. To
quantify UCP1-mediated proton leak, we determined oxygen con-
sumption as a measure for proton leak rate at the highest common
potential. A common potential for quantitative curve comparisons is
necessary as proton motive force is the driving force of the proton
leak with pronounced non-ohmic nature at higher potentials. At
the highest common potential of ∼154 mV, oxygen consumption
was about 4-fold (Pb0.0001, N=7) increased in transgenic mice
(100.15 nmol O min−1 mg−1+/−7.75) as compared to wildtype
controls (27.07 nmol O min−1 mg−1+/−2.25). We conﬁrmed the
genotypes of the mice by blotting skeletal muscle protein and probingFig. 1. Proton leak kinetics showing basal proton conductance of isolated skeletal
muscle mitochondria from HSA-mUCP1 transgenic mice (open symbols; n=6) and wt
littermate controls (black symbols; n=3). The proton conductance of transgenic
mitochondria was signiﬁcantly elevated compared to wildtype mitochondria.against mouse UCP1. Furthermore, we also analyzed UCP3 levels
which were found to be unchanged (Supplement 1a).3.2. Effect of the UCP1-inhibitor GDP and the activator palmitate on
proton conductance
We further explored UCP1 function in skeletal muscle mitochon-
dria by adding an inhibiting purine nucleotide, GDP, and an activating
free fatty acid, palmitate, respectively, and monitored the effect on
proton conductance (Fig. 2).
In transgenic mice, the addition of GDP shifted oxygen consump-
tion at 154 mV back to wildtype level (transgenic GDP:
29.31 nmol O min−1+/−2.72) while the compound GDP had no
effect in wildtype mice (26.65 nmol O min−1+/−1.18). Comparing
transgenic and wildtype mice in the presence of GDP, there were no
signiﬁcant genotype effects apparent (P=0.09, N=3–7).
Palmitate is known to overcome GDP inhibition by simple compet-
itive kinetics [28]. 100 μM palmitate, approximately resulting in 11 nM
free fatty acids in the presence of 0.3% BSA [26] shifted the proton leak
curve of GDP–inhibited UCP1 upwards. Comparing at the highest
membrane potential of ∼167 mV, oxygen consumption rate increased
from 50.31 nmol O min−1+/−6.73 to 99.81 nmol O min−1+/-5.60.
Palmitate-induced uncoupling was not apparent at state 4 potential in
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−4.95; Palmitate: 183.59 mV, 131.63 nmol O min−1+/−6.48).
3.3. Controlling for effects putatively mediated by the adenine nucleotide
translocase (ANT)
It has been demonstrated that uncoupling activity mediated by the
ANT can also be increased by fatty acids [29] and recently, that GDP is
able to inhibit ANT uncoupling [30]. To control for potential
misinterpretation of the data, we ﬁrst determined the amount of
ANT by CAT titration in skeletal muscle mitochondria of transgenic
and wildtype mice. ANT contents were similar in transgenic
(2.56 nmol ANT/mg protein) and wildtype (2.73 nmol/mg protein)
mice. An illustration of the CAT titration can be found in supplement
1b. Furthermore, we repeated the effects of palmitate and GDP in the
presence of CAT, an exempliﬁed measurement is shown in Fig. 3. Also,
no effect of CAT by palmitate and GDP was found in proton
conductance (graphs are shown in supplement 1c).
3.4. Genotypic differences in substrate oxidation measured as
mitochondrial respiration on succinate
Although differences in proton conductance between genotypes
can be explained conclusively by the presence of UCP1 activity, we
initially found differences in state 4 respiration which may be
explained by different substrate oxidation rates between genotypes.
Therefore, we also measured state 2 respiration in the presence of
succinate and state 3 respiration induced by 600 μM ADP (Fig. 4). TheFig. 3. Representative parallel measurement of mitochondrial oxygen consumption
illustrated as decline of oxygen concentration (Jo) and membrane potential as the
uptake of the membrane potential dependent uptake of TPMP+ (mV) along a time
scale. The emphasis is to illustrate the effects of palmitate and GDP in the presence of
CAT (inhibiting the ANT) in wildtype and HSA-mUCP1 transgenic mouse. In contrast to
Fig. 2, UCP1 was activated ﬁrst with fatty acid and then inhibited with GDP.reduced oxygen consumption in transgenic mice suggests a decrease
in substrate oxidation capacity. This assumption is further corrobo-
rated when plotting oxygen consumption rate against membrane
potential obtained from Fig. 3 (see supplement 1d).
3.5. Measurement of mitochondrial hydrogen peroxide release as a
measure of superoxide production
It has been hypothesized that mild uncoupling of the respiratory
chain leads to prevention of mitochondrial ROS production possibly
reducing age-related dysfunctions. Here we estimated mitochondrial
superoxide production by a standard Amplex red assay measuring
mitochondrial hydrogen peroxide release. To assist the conversion of
escaping superoxide to hydrogen peroxide, saturating amounts of
superoxide dismutase were added, similar to Lambert et al. [31]. All
measurements were performed in the presence of oligomycin,
shifting mitochondria to state 4 and getting maximum membrane
potential, also mimicking a state close to resting of muscle.
When comparing transgenic with wildtype mitochondria (Fig. 5),
we found that superoxide production levels were about 76% lower in
transgenics (wt: 2.79 nmol superoxide min−1 mg−1 mitochondrial
protein vs transgenic: 0.66 nmol superoxide min−1 mg−1 mito-
chondrial protein). The administration of 1 mM GDP increased
superoxide production to almost wildtype levels (2.77 nmol
superoxide min−1 mg−1 mitochondrial protein) while in wildtypes,
1 mM GDP almost doubled the basal value to 6.69 nmol
superoxide min−1 mg−1 mitochondrial protein, notably without
detectable differences in proton conductance (compare to Fig. 2).
In the presence of rotenone, preventing reverse electron transfer,
superoxide production decreased signiﬁcantly inwildtypemice, while
the low levels from transgenics were slightly elevated.
4. Discussion
In this study we demonstrate native behavior of mouse UCP1
ectopically expressed in skeletal muscle of our transgenic mouse line
[24]. Furthermore, UCP1 mitigated superoxide production by reverse
electron transfer as determined by detection of mitochondrial
hydrogen peroxide release which is indicative of mitochondrial
superoxide production.
4.1. Uncoupling protein 1 activity in skeletal muscle of transgenic mice
displays native behavior
In order to unambiguously relate physiological and biochemical
parameters to the presence or absence of a functional UCP1 in skeletal
muscle, it is of major importance to characterize UCP1-mediated
proton conductance. In the light of problems that occurred during UCP
expression in other cell systems [32], here we aimed to identify any
arbitrary proton leak activity which can be caused by proteins not
properly folded and inserted into the mitochondrial inner membrane.
Our data showed that UCP1 expressed in skeletal muscle catalyzes a
proton leak which could be fully regulated with free fatty acids
(palmitate) and purine nucleotides (GDP). In the presence of the
purine nucleotide GDP, we found no signiﬁcant difference in proton
conductance between wildtype and transgenic mice and therefore
excluded any artiﬁcial uncoupling. The typical activator of UCP1, a
fatty acid, palmitate, overcame GDP-inhibition in transgenic mice and
increased proton conductance while there were no effects of 100 μM
palmitate in wildtype.
Although purine nucleotides and fatty acids are generally regarded
as typical activators/inhibitors of UCP1, another abundant mitochon-
drial carrier protein, the adenine nucleotide translocase (ANT), has
been shown to also uncouple the respiratory chain from ATP synthesis
which can be modulated by fatty acids [33] and GDP [30]. It was
therefore necessary to re-investigate the activity of mouse UCP1 in
Fig. 4. Respiration rates of wildtype (black columns) and HSA-UCP1 transgenic (white columns) skeletal muscle mitochondria. Mitochondria respired on succinate, state 2
respiration was performed in the presence of rotenone, state 3 respiration induced by 600 μM ADP, and mitochondria shifted into state 4 with oligomycin. ⁎Pb0.02; ⁎⁎Pb0,01).
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uncoupling activity of the ANT. In these experiments, we could show
that all effects on UCP1 activity were still preserved. In fact, we also
determined the ANT concentration per milligram mitochondrial
protein which was not affected by ectopic UCP1 expression.
4.2. UCP1 gene expression in skeletal muscle reduces the risk of reverse
electron transfer and the production of reactive oxygen species
It has been hypothesized that mild uncoupling prevents mito-
chondrial superoxide production [34]. Using succinate as substrate,we
investigatedwhether skeletalmuscleUCP1has an effect on superoxide
production, analyzing the production of forward and reverse electron
transfer in mitochondrial state 4. We found that superoxide produc-
tion was about 76% lower in UCP1 expressing mice. In the presence of
rotenone, preventing reverse electron transfer at complex I when
energized with complex II substrate, superoxide production in
transgenic mice was slightly elevated, while there was a signiﬁcant
decrease in wildtype mice as described previously for other rodent
species [35]. The negligible elevation of signal caused by rotenone in
transgenic mitochondria may be caused by residual endogenous
substrates feeding into complex I. However, this had apparently no
signiﬁcant impact. Administration of GDP increased superoxide
production in transgenics to almost wildtype level. GDP also had an
effect on wildtype mitochondria, doubling the production rate.
Although we detect no apparent mitochondrial uncoupling between
proton leak curves in absence or presence of GDP in wildtype
mitochondria, it may be that other uncouplers also contribute to the
prevention of superoxide with UCP3 being one of the candidates. In
fact, Talbot et al. showed strongUCP3 dependent effects on superoxide
production in the presence of GDP resulting in a 25% decrease on
aconitase activity [36]. Considering that the reduction state of theFig. 5. Rates of superoxide production (calculated by 1:2 stoichiometry of H2O2 production
wildtype mice (black columns). (A) Control medium; (B) addition of 1 mM GDP to inhibit UC
Bars show means+/−SEM (⁎Pb0.05).respiratory chain increases with membrane potential exponentially at
high potentials, small activities of UCP3 may cause this effect in
wildtype mice having higher potentials than transgenics. We found,
however, no differences in skeletal muscle UCP3 protein content
between transgenic and wildtype mice. On the other hand, our results
clearly show that UCP1 has a preventive effect on superoxide
production in transgenic mice which in turn may slow down the
accumulation of damage in the muscle. In accordance to our
observations, previous studies observed an increase ofmedian survival
in transgenic mice and lowered age-related disease [16]. The
manipulation of mitochondrial superoxide production by uncoupling
activity in skeletal muscle may therefore represent an interesting
therapeutic target to decrease oxidative stress, not only in muscle.
4.3. Does UCP1 cause a depression of substrate oxidation in skeletal
muscle mitochondria?
During proton leak titration we observed that although proton
conductance in transgenic mouse mitochondria was elevated there
was a decrease in state 4 respiration indicating a depression in
substrate oxidation (Fig. 1). We found that state 2, 3 and state 4
respirationwere decreased in transgenicmusclemitochondria (Fig. 4)
strongly suggesting that succinate dehydrogenase activity in mito-
chondria of transgenic mice is decreased. In this study, we did not
further explore the nature of this secondary effect of UCP1 expression
in skeletal muscle. We found, however, two other studies investigat-
ing mitochondrial respiration of UCP1-containing mitochondria: in a
study by Couplan et al. [15], no depression of mitochondrial
respiration was apparent in their mouse model. Unfortunately, the
other study investigating UCP1 muscle gene transfer [37] “normal-
ised” their respiration data to chemical uncoupler values, which
masks any effects on substrate oxidation.) of isolated skeletal muscle mitochondria from transgenic mice (white columns) and
P1 activity; (C) addition of 4 μM rotenone to inhibit complex I-derived ROS production.
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be noticed in Couplan et al.: presumably due to a switch from fast to
slowmuscle ﬁbres, the response towards alpha-glycerol phosphate in
transgenic mice was blunted [15].
Interestingly, over-expression of UCP3 in skeletal muscle of mice
led to a decrease in state 3 respiration in isolated mitochondria when
using succinate as a substrate but increased when using palmitate
[38]. Here we only used succinate, it thus remains to be investigated if
other substrates might have different effects on maximum respiration
rates in our model.
In cultured neurons, mild uncoupling by FCCP decreased spare
respiratory capacity, similar to our observations of depressed
substrate oxidation capacity in skeletal muscle mitochondria [39].
Mild uncoupling in neurons increased toxicity to glutamate and
oxidative stress, presumably due to mismatching energetic demands.
Therefore, mild uncouplingmay not be beneﬁcial in all tissues, further
refuting the use of general uncouplers such as DNP but promoting
research on tissue-speciﬁc uncoupling.
4.4. Relating physiological observations to skeletal muscle UCP1 function
Interestingly, the presence of UCP1 in muscle leads to physiolog-
ical effects (e.g. reduction in body weight) that can be explained by
increased energy dissipation in skeletal muscle. Our data show that
UCP1 can be fully inhibited with purine nucleotides. Given the
intracellular ATP/ADP concentrations, UCP1 in the muscle cell should
be inhibited at all times, similar to the situation in the brown
adipocyte without a cold stimulus, when levels of free fatty acids and
lipolysis are low. In fact, the muscle cell artiﬁcially hosting UCP1 does
presumably not possess the same cellular machinery that assists the
uptake and breakdown of lipids at high throughput rates as found for
brown adipose tissue. Furthermore, the activation of UCP1 by cold-
induced noradrenaline is probably also not present in skeletal muscle.
If UCP1 is inhibited, the question arises why there are obvious
phenotypes associated with skeletal muscle uncoupling. Recently, it
has been found that brown adipose tissue UCP1 deﬁciency induces
obesity and abolishes diet-induced thermogenesis under thermo-
neutral conditions, even when fed on control diet [6]. This emphasizes
that UCP1 under physiological conditions is either not fully inhibited
and may conduct protons below detection levels. It may also well be
that the increased fatty acid metabolism and circulation induced by
moderate cold (normal animal maintenance is between 22 and 24 °C)
is sufﬁcient to activate UCP1 in skeletal muscle.
The importance of this study is the demonstration of potent
regulation of UCP1 protein function in skeletal muscle that further
corroborates the beneﬁcial effects of skeletal muscle mitochondrial
uncoupling on obesity [14,24], insulin resistance [13,14,23], and
aging [16].
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